Ahmad Kamal Abou-Foul
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ahmad Kamal Abou-Foul has a total of 103 co-authors. Here are the top co-authors by number of shared publications:
- Hisham Mehanna
Institute of Head and Neck Studies and Education, University of Birmingham, B15 2TT, UK
3 shared publications J. Mirza
Oral and Maxillo-Facial surgery department, Oxford University hospitals, Oxford OX3 9DU, UK
2 shared publicationsP. Anand
Oral and Maxillo-Facial surgery department, Oxford University hospitals, Oxford OX3 9DU, UK
2 shared publicationsA Taghi
Department of Otolaryngology, Head and Neck Surgery,Imperial College Healthcare NHS Trust,London,UK
1 shared publication- A. Fasanmade
Division of Oral & Maxillofacial Surgery, Head and Neck Surgery Supra-Regional Unit, Churchill Hospital, Oxford University Hospitals NHS Trust, Oxford OX3 7LE, UK
1 shared publication A. Holden
Oral and Maxillo-facial surgery department, Oxford University hospitals, Oxford, UK, OX3 9DU
1 shared publication
Latest Publications
- 27 October 2026
- Published by Wiley in Clinical Otolaryngology
Risk of Malignancy in Asymptomatic Unilateral Tonsillar Enlargement in Adults and Children: A Systematic Review and Meta‐Analysis
Background: Unilateral tonsillar enlargement (UTE) may raise concern for malignancy and frequently prompt diagnostic tonsillectomy. However, when present in the absence of additional suspicious features, the true risk of malignancy remains uncertain. This study aimed to evaluate the prevalence of malignant histology in patients undergoing tonsillectomy for isolated asymptomatic UTE. Methods: A systematic review was conducted in accordance with PRISMA guidance. MEDLINE, EMBASE, EMCARE, PubMed and the Cochrane Library were searched from inception to 22 September 2025. Studies reporting histopathological outcomes in patients undergoing tonsillectomy for isolated asymptomatic UTE were included. A meta‐analysis of proportions was performed for adult‐only cohorts. Results: Eighteen studies comprising 1582 tonsillectomy specimens met the inclusion criteria. No malignant cases were identified in paediatric patients (0/751; 95% CI 0.00%–0.49%). Among adult patients ( n = 712), six malignant cases were identified, all of which were lymphoproliferative in origin. Meta‐analysis of adult‐only studies demonstrated a pooled prevalence of 2.04% (95% CI 0.98%–4.22%) with low heterogeneity ( I 2 = 15.2%). The crude overall prevalence of malignancy across all cohorts was 0.38% (95% CI 0.14%–0.82%). Conclusion: Isolated asymptomatic UTE is associated with an extremely low risk of malignancy, particularly in paediatric patients. Routine diagnostic tonsillectomy is unlikely to be justified in children and should be selectively considered in adults based on clinical risk factors. Careful clinical assessment remains essential in guiding management. Trial Registration: PROSPERO: CRD420261423941
- 27 October 2026
- Published by Wiley in Clinical Otolaryngology
Risk of Malignancy in Asymptomatic Unilateral Tonsillar Enlargement in Adults and Children: A Systematic Review and Meta‐Analysis
Background: Unilateral tonsillar enlargement (UTE) may raise concern for malignancy and frequently prompt diagnostic tonsillectomy. However, when present in the absence of additional suspicious features, the true risk of malignancy remains uncertain. This study aimed to evaluate the prevalence of malignant histology in patients undergoing tonsillectomy for isolated asymptomatic UTE. Methods: A systematic review was conducted in accordance with PRISMA guidance. MEDLINE, EMBASE, EMCARE, PubMed and the Cochrane Library were searched from inception to 22 September 2025. Studies reporting histopathological outcomes in patients undergoing tonsillectomy for isolated asymptomatic UTE were included. A meta‐analysis of proportions was performed for adult‐only cohorts. Results: Eighteen studies comprising 1582 tonsillectomy specimens met the inclusion criteria. No malignant cases were identified in paediatric patients (0/751; 95% CI 0.00%–0.49%). Among adult patients ( n = 712), six malignant cases were identified, all of which were lymphoproliferative in origin. Meta‐analysis of adult‐only studies demonstrated a pooled prevalence of 2.04% (95% CI 0.98%–4.22%) with low heterogeneity ( I 2 = 15.2%). The crude overall prevalence of malignancy across all cohorts was 0.38% (95% CI 0.14%–0.82%). Conclusion: Isolated asymptomatic UTE is associated with an extremely low risk of malignancy, particularly in paediatric patients. Routine diagnostic tonsillectomy is unlikely to be justified in children and should be selectively considered in adults based on clinical risk factors. Careful clinical assessment remains essential in guiding management. Trial Registration: PROSPERO: CRD420261423941
- Open Access
- 13 July 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e83598
Toward a Better Paradigm for Head and Neck Cancer Treatment Applying AI (HNC-TACTIC): Protocol for an International Cohort Study of Electronic Health Records
Background: Head and neck squamous cell carcinomas (HNSCCs) cause considerable morbidity and mortality. Multimodal treatment strategies can cause significant toxicity, and therapy options are limited for recurrent disease. Immunotherapy has emerged as a promising approach. However, patient response variability underscores the need for better predictive markers. Objective: This study aims to use artificial intelligence to develop two predictive models in patients with HNSCC to assess (1) progression or recurrence following primary curative treatment and (2) long-term survival after immunotherapy schemes in recurrent and metastatic disease. This study will also describe the characteristics of patients with early, locally advanced, and recurrent or metastatic cancers. Methods: This is a retrospective, observational study of data captured in electronic health records (EHRs) from participating hospitals between January 1, 2014, and December 31, 2021. This study’s population comprises adults diagnosed with HNSCC at any stage. Study variables, including demographics, comorbidities, clinical variables, treatments, and outcomes, will be extracted using EHRead, a technology that applies natural language processing and machine learning to extract and analyze structured and unstructured clinical information in deidentified EHRs. Predictive models based on dynamic risk stratification for treatment response and progression or recurrence will be developed using multivariable logistic regressions, decision tree classifiers, and random forest approaches. Descriptive and outcome analyses will be shown for different anatomic subsites and stratified by stage and treatment. Results: This study began enrolling sites in July 2021 and is currently ongoing. By December 2025, data from 10 centers has been collected, comprising a total of 151,934,990 EHRs from 2,159,719 patients. Conclusions: Development of predictive models using artificial intelligence will advance clinical understanding of HNSCC to improve patient outcomes.
- 13 July 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e83598
Open AccessToward a Better Paradigm for Head and Neck Cancer Treatment Applying AI (HNC-TACTIC): Protocol for an International Cohort Study of Electronic Health Records
Background: Head and neck squamous cell carcinomas (HNSCCs) cause considerable morbidity and mortality. Multimodal treatment strategies can cause significant toxicity, and therapy options are limited for recurrent disease. Immunotherapy has emerged as a promising approach. However, patient response variability underscores the need for better predictive markers. Objective: This study aims to use artificial intelligence to develop two predictive models in patients with HNSCC to assess (1) progression or recurrence following primary curative treatment and (2) long-term survival after immunotherapy schemes in recurrent and metastatic disease. This study will also describe the characteristics of patients with early, locally advanced, and recurrent or metastatic cancers. Methods: This is a retrospective, observational study of data captured in electronic health records (EHRs) from participating hospitals between January 1, 2014, and December 31, 2021. This study’s population comprises adults diagnosed with HNSCC at any stage. Study variables, including demographics, comorbidities, clinical variables, treatments, and outcomes, will be extracted using EHRead, a technology that applies natural language processing and machine learning to extract and analyze structured and unstructured clinical information in deidentified EHRs. Predictive models based on dynamic risk stratification for treatment response and progression or recurrence will be developed using multivariable logistic regressions, decision tree classifiers, and random forest approaches. Descriptive and outcome analyses will be shown for different anatomic subsites and stratified by stage and treatment. Results: This study began enrolling sites in July 2021 and is currently ongoing. By December 2025, data from 10 centers has been collected, comprising a total of 151,934,990 EHRs from 2,159,719 patients. Conclusions: Development of predictive models using artificial intelligence will advance clinical understanding of HNSCC to improve patient outcomes.
- Open Access
- 26 April 2026
- Published by Elsevier in Oral Oncology
- Vol. 178, 107980
Correlation between head and neck radiologists reporting on extranodal extension detected on radiological imaging: A head and neck cancer international group multinational study
- 26 April 2026
- Published by Elsevier in Oral Oncology
- Vol. 178, 107980
Open AccessCorrelation between head and neck radiologists reporting on extranodal extension detected on radiological imaging: A head and neck cancer international group multinational study
- Open Access
- 4 April 2023
- Published by Wiley in Clinical Otolaryngology
- Vol. 48 (4) , 613-622
Patient preference for commonly‐used, head and neck cancer‐specific quality of life questionnaires in the follow‐up setting (Determin): A multi‐centre randomised controlled trial and mixed methods study
Background: Quality of life (QoL) assessment forms an integral part of modern cancer care and research. The aim of this study is to determine patients' preferences and willingness to complete commonly used head‐and‐neck cancer (HNC) QoL questionnaires (QLQs) in routine follow‐up clinics.Methods: This is a randomised control trial of 583 subjects from 17 centres during follow‐up after treatment for oral, oropharyngeal or laryngeal cancer. Subjects completed three structured validated questionnaires: EORTC QLQ‐HN35; FACT‐HN and UW‐QOL, and an unstructured patient‐generated list. The order of questionnaire presentation was randomised, and subjects were stratified by disease site and stage. Patients self‐rated the questionnaires they found most helpful to communicate their health concerns to their clinicians.Results: Of the 558 respondents, 82% (457) found QLQs useful to communicate their health concerns to their clinician (OR = 15.76; 95% CI 10.83–22.94). Patients preferred the structured disease‐specific instruments (OR 8.79; 95% CI 5.99–12.91), while the open list was the most disliked (OR = 4.25; 95% CI 3.04–5.94). There was no difference in preference by treatment modality. More women preferred the FACT‐HN (OR = 3.01, 95% CI 1.05–8.62), and patients under 70 preferred EORTC QLQ‐HN35 (OR = 3.14, 95% CI 1.3–7.59). However, only 55% of patients expressed preference to complete questionnaires routinely at the clinic.Conclusions: Most patients found QLQs helpful during their follow‐up and 55% supported routine questionnaires in follow‐up clinics. Males and people over 70 years old were the least willing to complete the routine questionnaires and preferred shorter questionnaires (e.g., UW‐QOL). Women preferred FACT‐HN, and younger patients preferred EORTC QLQ‐HN35. Reasons for the reluctance to complete questionnaires require elucidation.
- 4 April 2023
- Published by Wiley in Clinical Otolaryngology
- Vol. 48 (4) , 613-622
Open AccessPatient preference for commonly‐used, head and neck cancer‐specific quality of life questionnaires in the follow‐up setting (Determin): A multi‐centre randomised controlled trial and mixed methods study
Background: Quality of life (QoL) assessment forms an integral part of modern cancer care and research. The aim of this study is to determine patients' preferences and willingness to complete commonly used head‐and‐neck cancer (HNC) QoL questionnaires (QLQs) in routine follow‐up clinics.Methods: This is a randomised control trial of 583 subjects from 17 centres during follow‐up after treatment for oral, oropharyngeal or laryngeal cancer. Subjects completed three structured validated questionnaires: EORTC QLQ‐HN35; FACT‐HN and UW‐QOL, and an unstructured patient‐generated list. The order of questionnaire presentation was randomised, and subjects were stratified by disease site and stage. Patients self‐rated the questionnaires they found most helpful to communicate their health concerns to their clinicians.Results: Of the 558 respondents, 82% (457) found QLQs useful to communicate their health concerns to their clinician (OR = 15.76; 95% CI 10.83–22.94). Patients preferred the structured disease‐specific instruments (OR 8.79; 95% CI 5.99–12.91), while the open list was the most disliked (OR = 4.25; 95% CI 3.04–5.94). There was no difference in preference by treatment modality. More women preferred the FACT‐HN (OR = 3.01, 95% CI 1.05–8.62), and patients under 70 preferred EORTC QLQ‐HN35 (OR = 3.14, 95% CI 1.3–7.59). However, only 55% of patients expressed preference to complete questionnaires routinely at the clinic.Conclusions: Most patients found QLQs helpful during their follow‐up and 55% supported routine questionnaires in follow‐up clinics. Males and people over 70 years old were the least willing to complete the routine questionnaires and preferred shorter questionnaires (e.g., UW‐QOL). Women preferred FACT‐HN, and younger patients preferred EORTC QLQ‐HN35. Reasons for the reluctance to complete questionnaires require elucidation.
- 16 September 2021
- Published by Cambridge University Press (CUP) in The Journal of Laryngology & Otology
- Vol. 135 (11) , 1025-1030
Cervical lymphadenopathy following coronavirus disease 2019 vaccine: clinical characteristics and implications for head and neck cancer services
Objective: Patients with coronavirus disease vaccine associated lymphadenopathy are increasingly being referred to healthcare services. This work is the first to report on the incidence, clinical course and imaging features of coronavirus disease vaccine associated cervical lymphadenopathy, with special emphasis on the implications for head and neck cancer services.Methods: This was a retrospective cohort study of all patients referred to our head and neck cancer clinics between 16 December 2020 and 12 March 2021. The main outcomes measured were the proportion of patients with vaccine-associated cervical lymphadenopathy, and the clinical and imaging characteristics.Results: The incidence of vaccine-associated cervical lymphadenopathy referrals was 14.8 per cent (n = 13). Five patients (38.5 per cent) had abnormal-looking enlarged and rounded nodes with increased vascularity. Only seven patients (53.9 per cent) reported full resolution within an average of 3.1 ± 2.3 weeks.Conclusion: Coronavirus disease vaccine associated cervical lymphadenopathy can mimic malignant lymphadenopathy and therefore might prove challenging to diagnose and manage correctly. Healthcare services may encounter a significant increase in referrals.
- 16 September 2021
- Published by Cambridge University Press (CUP) in The Journal of Laryngology & Otology
- Vol. 135 (11) , 1025-1030
Cervical lymphadenopathy following coronavirus disease 2019 vaccine: clinical characteristics and implications for head and neck cancer services
Objective: Patients with coronavirus disease vaccine associated lymphadenopathy are increasingly being referred to healthcare services. This work is the first to report on the incidence, clinical course and imaging features of coronavirus disease vaccine associated cervical lymphadenopathy, with special emphasis on the implications for head and neck cancer services.Methods: This was a retrospective cohort study of all patients referred to our head and neck cancer clinics between 16 December 2020 and 12 March 2021. The main outcomes measured were the proportion of patients with vaccine-associated cervical lymphadenopathy, and the clinical and imaging characteristics.Results: The incidence of vaccine-associated cervical lymphadenopathy referrals was 14.8 per cent (n = 13). Five patients (38.5 per cent) had abnormal-looking enlarged and rounded nodes with increased vascularity. Only seven patients (53.9 per cent) reported full resolution within an average of 3.1 ± 2.3 weeks.Conclusion: Coronavirus disease vaccine associated cervical lymphadenopathy can mimic malignant lymphadenopathy and therefore might prove challenging to diagnose and manage correctly. Healthcare services may encounter a significant increase in referrals.
- 1 July 2021
- Published by Elsevier in Oral Oncology
- Vol. 118, 20
P-257 Cervical lymphadenopathy following COVID-19 vaccine: Clinical characteristics and implications for head and neck cancer services
- 1 July 2021
- Published by Elsevier in Oral Oncology
- Vol. 118, 20
P-257 Cervical lymphadenopathy following COVID-19 vaccine: Clinical characteristics and implications for head and neck cancer services
- Open Access
- 15 April 2021
- Published by Springer Nature in Cureus
- Vol. 13 (4)
Correlation Between Thyroid Fine Needle Aspiration Cytology and Postoperative Histology: A 10-Year Single-Centre Experience
Introduction Fine needle aspiration cytology (FNAC) forms part of the routine workup for suspicious thyroid nodules. Whilst cytological analysis is less precise than histological assessment, it is quick and easy to perform and may avoid the need for invasive and potentially risky surgery. Methods This retrospective study spanned a 10-year period comparing preoperative FNAC with postoperative histology results to establish the accuracy of diagnosis and malignancy rates within our population. These results were then compared to the published figures in the literature. Results The histological reports of 659 consecutive cases of thyroid surgery between 2006 and 2015 were retrieved from our hospital database. Among the 471 patients (71.5%) who underwent preoperative FNAC, the postoperative histology was reported as benign in 352 (74.7%) and malignant in 119 cases (25.3%). Papillary thyroid cancer (PTC) was the commonest histological diagnosis. Thy1 grade was reported in 165 (30%) cases, with 19.4% having a final histological diagnosis of malignancy. In the Thy2 group, 85.3% of patients had a benign final histological diagnosis, while 14.7% had malignancy (false-negative results). Malignancy was found in 89% of Thy4 and 100% of Thy5 group patients. Conclusions Rates of malignancy varied considerably from those in the published literature. Each centre should be able to quote a local malignancy rate during patient counselling. It is also prudent for all units performing thyroid diagnostics to investigate the factors that might lead to inaccuracies in reporting.
- 15 April 2021
- Published by Springer Nature in Cureus
- Vol. 13 (4)
Open AccessCorrelation Between Thyroid Fine Needle Aspiration Cytology and Postoperative Histology: A 10-Year Single-Centre Experience
Introduction Fine needle aspiration cytology (FNAC) forms part of the routine workup for suspicious thyroid nodules. Whilst cytological analysis is less precise than histological assessment, it is quick and easy to perform and may avoid the need for invasive and potentially risky surgery. Methods This retrospective study spanned a 10-year period comparing preoperative FNAC with postoperative histology results to establish the accuracy of diagnosis and malignancy rates within our population. These results were then compared to the published figures in the literature. Results The histological reports of 659 consecutive cases of thyroid surgery between 2006 and 2015 were retrieved from our hospital database. Among the 471 patients (71.5%) who underwent preoperative FNAC, the postoperative histology was reported as benign in 352 (74.7%) and malignant in 119 cases (25.3%). Papillary thyroid cancer (PTC) was the commonest histological diagnosis. Thy1 grade was reported in 165 (30%) cases, with 19.4% having a final histological diagnosis of malignancy. In the Thy2 group, 85.3% of patients had a benign final histological diagnosis, while 14.7% had malignancy (false-negative results). Malignancy was found in 89% of Thy4 and 100% of Thy5 group patients. Conclusions Rates of malignancy varied considerably from those in the published literature. Each centre should be able to quote a local malignancy rate during patient counselling. It is also prudent for all units performing thyroid diagnostics to investigate the factors that might lead to inaccuracies in reporting.
- 7 October 2020
- Published by Cambridge University Press (CUP) in The Journal of Laryngology & Otology
- Vol. 134 (10) , 856-862
Surgical anatomy of the lymphatic drainage of the salivary glands: a systematic review
Background: Nodal metastasis in salivary gland malignancies has important clinical implications; a good understanding of their complex anatomy is paramount to the head and neck surgeon.Methods: A contemporary and comprehensive literature review was conducted of the lymphatic drainage of the salivary glands, with special emphasis on its surgical applications.Results: The parotid gland has extraglandular and intraglandular nodes acting as a single functional drainage unit. Intraglandular parotid notes are unique to the parotid gland, and consist of a larger superficial group and a smaller deep group. The presence of intraglandular submandibular nodes, as described by early anatomists, is much debated nowadays. The sublingual glands drain to the lingual lymph nodes, which are divided into median, intermediate and lateral groups.Conclusion: This review highlights the complex arrangements of lymph nodes draining the salivary glands. It may provide a valid anatomical explanation for the nodal metastasis patterns commonly seen in salivary gland malignancy.
- 7 October 2020
- Published by Cambridge University Press (CUP) in The Journal of Laryngology & Otology
- Vol. 134 (10) , 856-862
Surgical anatomy of the lymphatic drainage of the salivary glands: a systematic review
Background: Nodal metastasis in salivary gland malignancies has important clinical implications; a good understanding of their complex anatomy is paramount to the head and neck surgeon.Methods: A contemporary and comprehensive literature review was conducted of the lymphatic drainage of the salivary glands, with special emphasis on its surgical applications.Results: The parotid gland has extraglandular and intraglandular nodes acting as a single functional drainage unit. Intraglandular parotid notes are unique to the parotid gland, and consist of a larger superficial group and a smaller deep group. The presence of intraglandular submandibular nodes, as described by early anatomists, is much debated nowadays. The sublingual glands drain to the lingual lymph nodes, which are divided into median, intermediate and lateral groups.Conclusion: This review highlights the complex arrangements of lymph nodes draining the salivary glands. It may provide a valid anatomical explanation for the nodal metastasis patterns commonly seen in salivary gland malignancy.
- Open Access
- 1 January 2020
- Published by Taylor & Francis in ClinicoEconomics and Outcomes Research
- Vol. ume 12, 13-21
Analysis of the Peri-Operative Cost of Non-Traumatic Major Lower Extremity Amputation in Jordan
Purpose: Non-traumatic major lower extremity amputation (NMLEA) is a commonly performed procedure that presents a substantial cost burden. Patients who undergo NMLEA are usually considered as a high-risk group with significant comorbidities, which translates into a protracted peri-operative course and increased health-care costs. The primary aim of this study was therefore to perform a contemporary peri-operative cost analysis of NMLEA performed in our center. We are a major tertiary referral hospital that provides vascular surgery services to the entire northern counties in Jordan. We also aimed to assess the various factors that influence the cost of NMLEA in less economically developed countries. Methods: Records of all patients who underwent NMLEA at King Abdullah University Hospital between January 2012 and December 2017 were retrieved. Total inpatient cost was calculated and analyzed against different patients’ variables. Results: A total of 140 patients underwent NMLEA between 2012 and 2017 in our facility. Below-knee amputations accounted for 110 cases, while above-knee amputations included 30 patients. Approximately two-thirds of the cases (61.4%) were males, with average age of the patients being approximately 62.9 years. The commonest comorbidities were diabetes mellitus and hypertension, which were recorded in 89.3% and 80.3% of the patients, respectively. The average operative time was 133.0 ± 10.8 mins, and the average length of stay (LOS) was 6.7±0.4 days. The mean cost for amputations was 4904.7± 429.3 United States dollars. Multiple linear regression analysis demonstrated that LOS and admission-to-operation time were the independent predictors of cost. Conclusion: Delayed amputations and prolonged LOS remain the most important determinants for the peri-operative cost of NMLEA. When amputation is deemed inevitable, an expedited multidisciplinary approach may possibly reduce undue delays and result in cost-effective delivery of this age-old remedy.
- 1 January 2020
- Published by Taylor & Francis in ClinicoEconomics and Outcomes Research
- Vol. ume 12, 13-21
Open AccessAnalysis of the Peri-Operative Cost of Non-Traumatic Major Lower Extremity Amputation in Jordan
Purpose: Non-traumatic major lower extremity amputation (NMLEA) is a commonly performed procedure that presents a substantial cost burden. Patients who undergo NMLEA are usually considered as a high-risk group with significant comorbidities, which translates into a protracted peri-operative course and increased health-care costs. The primary aim of this study was therefore to perform a contemporary peri-operative cost analysis of NMLEA performed in our center. We are a major tertiary referral hospital that provides vascular surgery services to the entire northern counties in Jordan. We also aimed to assess the various factors that influence the cost of NMLEA in less economically developed countries. Methods: Records of all patients who underwent NMLEA at King Abdullah University Hospital between January 2012 and December 2017 were retrieved. Total inpatient cost was calculated and analyzed against different patients’ variables. Results: A total of 140 patients underwent NMLEA between 2012 and 2017 in our facility. Below-knee amputations accounted for 110 cases, while above-knee amputations included 30 patients. Approximately two-thirds of the cases (61.4%) were males, with average age of the patients being approximately 62.9 years. The commonest comorbidities were diabetes mellitus and hypertension, which were recorded in 89.3% and 80.3% of the patients, respectively. The average operative time was 133.0 ± 10.8 mins, and the average length of stay (LOS) was 6.7±0.4 days. The mean cost for amputations was 4904.7± 429.3 United States dollars. Multiple linear regression analysis demonstrated that LOS and admission-to-operation time were the independent predictors of cost. Conclusion: Delayed amputations and prolonged LOS remain the most important determinants for the peri-operative cost of NMLEA. When amputation is deemed inevitable, an expedited multidisciplinary approach may possibly reduce undue delays and result in cost-effective delivery of this age-old remedy.
- 16 December 2019
- Published by Springer Nature in Oral and Maxillofacial Surgery
- Vol. 24 (2) , 235-238
Treatment of calcium pyrophosphate deposition in the temporomandibular joint with resection and simultaneous reconstruction using a custom joint prosthesis
The authors present a rare case of calcium pyrophosphate deposition disease (CPPD) in the temporomandibular joint (TMJ), successfully treated with complete resection and immediate reconstruction using a custom-made prosthesis. This one-stage approach has prevented the patient from requiring two surgeries and has proven effective in the management of the condition.
- 16 December 2019
- Published by Springer Nature in Oral and Maxillofacial Surgery
- Vol. 24 (2) , 235-238
Treatment of calcium pyrophosphate deposition in the temporomandibular joint with resection and simultaneous reconstruction using a custom joint prosthesis
The authors present a rare case of calcium pyrophosphate deposition disease (CPPD) in the temporomandibular joint (TMJ), successfully treated with complete resection and immediate reconstruction using a custom-made prosthesis. This one-stage approach has prevented the patient from requiring two surgeries and has proven effective in the management of the condition.